Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1196-1201

  Codony Servat, Jordi ^a   Albanell, Joan ^a   Lopez Talavera, Juan Carlos ^a   Arribas, Joaquín ^a   Baselga, José ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE INHIBITOR; PERVANADATE; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER SURVIVAL; DIAGNOSTIC VALUE; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION;

BREAST NEOPLASMS; ENDOPEPTIDASES; HUMANS; HYDROXAMIC ACIDS; METALLOENDOPEPTIDASES; PHENYLALANINE; PHOSPHORYLATION; PROTEASE INHIBITORS; RECEPTOR, ERBB-2; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR CELLS, CULTURED; TYROSINE; VANADATES;

EID: 0033559210     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Coussens, L., Yang-Feng, T. L., Liao, Y. C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, V., Levinson, A., and Ullrich, A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (Washington DC), 230: 1132-1139, 1985.
2. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC). 235: 177-182, 1987.
3. Zabrecky, J. R., Lam, T., McKenzie, S. J., and Carney, W. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells. SK-BR-3. J. Biol. Chem., 266: 1716-1720, 1991.
4. Lin, Y. L., and Clinton, G. M. A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells. Oncogene, 6: 639-643, 1991.
5. Pupa, S. M., Menard, S., Morelli, D., Pozzi, B., De Palo, G., and Colnaghi, M. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolylic cleavage. Oncogene, 8: 2917-2923, 1993.
6. Brodowicz, T., Wiltschke, C., Budinsky, A. C., Krainer, M., Steger, G. G., and Zielinski, C. C. Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro. Int. J. Cancer, 73: 875-879, 1997.
7. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14: 737-744, 1996.
8. HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol., 16: 2659-2671, 1998.
9. Leitzel, K., Teramoto, Y., Konrad, K., Chinchilli, V. M., Volas, G., Grossberg, H., Harvey, H., Demers, L., and Lipton, A. Elevated serum c-erbB-2 antigen levels and decreased response to hormonal therapy of breast cancer. J. Clin. Oncol., 13: 1129-1235, 1995.
10. Yamauchi, H., O'Neill, A., Gelman, R. Carney, W., Tenney, D., Hosch, S., and Hayes, D. Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein. J. Clin. Oncol., 15: 18-25, 1996.
11. Harris, L. N., Trock, B., Berris, M., Esteva-Lorenzo, F., and Paik, S. The role of ERBB2 extracellular domain in predicting response to chemotherapy in breast cancer patients. Proc. Am. Soc. Clin. Oncol., 15: A96, 1996.
12. Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., and Aaronson, S. A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science (Washington, DC), 237: 178-182, 1987.
13. Segatto, O., King, C. R., Pierce, J. H., Di Fiore, P. P., and Aaronson, S. A. Different structural alterations up-regulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol. Cell. Biol., 8: 5570-5574, 1988.
14. Hooper, N. M., Karran, E. H., and Turner, A. J. Membrane protein secretases. Biochem. J., 321: 265-279, 1997.
15. Blobel, C. P. Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNF-α and Notch. Cell. 90: 589-592, 1998
16. Peschon, J., Slack, J., Reddy, P., Stocking, K., Sunnarborg, S., Lee, D., Rusell, W., Castner, R., Johnson, R., Fitzner, J., Boyce, N., Nelson, C., Kozlosky, M., Wolfson, M., Rauch, C., Cerretti, D., Paxton, R., March, C., and Black, R. An essential role for ectodomains shedding in mammalian development. Science (Washington, DC), 282: 1281-1284, 1998.
17. Scott, G. K., Robles, R., Park, J. W., Montgomery, P. A., Daniel, J., Holmes, W. E., Lee, J., Keller, G. A., Li, W., Fendly, B. M., Wood, W. I., Shepard, M., and Benz, C. C. A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol. Cell. Biol., 13: 2247-2257. 1993.
18. Beattie, G. J., and Smyth, J. F. Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin. Cancer Res., 4: 1899-1902, 1998.
19. Arribas, J., López-Casillas, F., and Massagué, J. Role of the juxtamembrane domains of the transforming growth factor-α precursor and the β-amyloid precursor protein in regulated ectodomain shedding. J. Biol. Chem., 272: 17160-17165, 1997.
20. Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T. K., Rose-John, S., and Massagué, J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem., 271: 11376-11382, 1996.
21. Black, R. A., Durie, F. H., Otten-Evans, C., Miller, R., Slack, J. L., Lynch, D. H., Castner, B., Mohler, K. M., Gerhart, M., Johnson, R. S., Itoh, Y., Okada, Y., and Nagase, H. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophys. Res. Commun., 225: 400-405, 1996.
22. Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knauper, V., Docherty, A. J., and Murphy, G. TNK-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett., 435: 39-44, 1998.
23. Vecchi, M., Baulida, J., and Carpenter, G. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J. Biol. Chem., 271: 18989-18995. 1996.
24. Reiland, J., Ott, V. L., Lebakken, C. S., Yeaman, C., McCarthy, J., and Rapraeger, A. C. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syrdecan-1. Biochem. J., 319: 39-47, 1996.
25. Slack, B. E., Breu, J., Petryniak, M. A., Srivastava, K., and Wurtman, R. J. Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor. J. Biol. Chem., 270, 8337-8344, 1995.
26. Roghani, M., Becherer, J. D., Moss, M. L., Atherton, R. E., Erdjument-Bromage, H., Arribas, J., Blackburn, R. K., Weskamp, G., Tempst, P., and Blobel, C. P. Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem., 274: 3531-3540, 1999.
27. Gomez, D. E., Alonso, D. F., Yoshiji, H., and Thorgeirsson, U. P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol., 74: 111-122, 1997.
28. Hargreaves, P. G., Wang, F., Antcliff, J., Murphy, G., Lawry, J., Russell, R. G., and Crocher, P. I. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor. Br. J. Haematol., 101: 694-702, 1998.
29. Lombard, M. A., Wallace, T. L., Kubicek, M. F., Petzold, G. L., Mitchell, M. A., Hendges, S. K., and Wilks, J. W. Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2. but not TIMP-1. inhibit shedding of tumor necrosis factor-α receptors in a human colon adenocarcinoma (Colo 205) cell line. Cancer Res., 58: 4001-4007, 1998.
30. Preece, G., Murphy, G., and Ager, A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J. Biol. Chem., 271: 11634-11640, 1996.